Next Article in Journal
Flow Synthesis of Pharmaceutical Intermediate Catalyzed by Immobilized DERA: Comparison of Different Immobilization Techniques and Reactor Designs
Previous Article in Journal
Cell-Specific Vulnerability of Human Glioblastoma and Astrocytoma Cells to Mephedrone—An In Vitro Study
Previous Article in Special Issue
The Role and Mechanisms of Antimicrobial Peptides in Overcoming Multidrug-Resistant Bacteria
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Quorum Sensing and Mobility Inhibition of Pathogenic Bacteria by Fulvifomes mexicanus sp. nov.

by
Angelica Bolaños-Nuñez
1,2,
Michelle Martínez-Pineda
1,
Ricardo Valenzuela
1,
Mario Figueroa
3,
Albert D. Patiño
3,
Everardo Curiel-Quesada
2,
César Ramiro Martínez-Gonzáles
4,
Rodrigo Villanueva-Silva
5,
Tania Raymundo
1,* and
Abigail Pérez-Valdespino
2,*
1
Departamento de Botánica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Col. Santo Tomás, Mexico City 11340, CDMX, Mexico
2
Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Col. Santo Tomás, Mexico City 11340, CDMX, Mexico
3
Departmento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, CDMX, Mexico
4
Herbario Micológico José Castillo Tovar, Instituto Tecnológico de Ciudad Victoria, Tecnológico Nacional de México, Boulevard Emilio Portes Gil No. 1301, Ciudad Victoria 87010, Tamaulipas, Mexico
5
Programa de Investigadoras e Investigadores por México de la Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Departamento de Toxicología, Centro de Investigaciones y Estudios Avanzados del IPN, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, Mexico City 07360, CDMX, Mexico
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(11), 2278; https://doi.org/10.3390/molecules30112278
Submission received: 26 March 2025 / Revised: 7 May 2025 / Accepted: 16 May 2025 / Published: 22 May 2025
(This article belongs to the Special Issue Antibacterial Agents from Natural Source, 2nd Edition)

Abstract

:
The development of antimicrobial resistance drives the search for molecules capable of inhibiting bacterial virulence. Fungi of the Basidiomycota phylum constitute an important source of compounds with antimicrobial activity. The present paper describes a new species named Fulvifomes mexicanus sp. nov. based on morphological and phylogenetic analyses. The methanolic extract of basidiome of this fungus inhibited the motility of Pseudomonas aeruginosa ATCC 9027 and the production of violacein by Chromobacterium violaceum CV026. The metabolomic study of the extract by liquid chromatography–high-resolution electrospray ionization mass spectrometry (LC-HRESIMS) and molecular networking analyses revealed the presence of a complex composition of metabolites including hispidin derivatives, terpenoids, phenols, furanones, alkylglycerols, pyrones, and γ-butyrolactones, among others. Overall, this work represents the first chemical and biological study of a new species of Fulvifomes mexicanus as a source of antipathogenic metabolites for the development of novel antimicrobial agents.

1. Introduction

The increasing prevalence of pathogenic bacteria resistant to commercially available drugs and the limited range of novel effective therapeutic agents represent a significant challenge for global health services [1]. In this context, it is crucial to identify novel compounds with antibiotic properties or substances that inhibit the expression of virulence genes in resistant bacteria and enable the host immune system to combat the infection effectively [2,3,4,5,6,7]. In many pathogenic bacteria, the expression of virulence factors is mainly controlled by Quorum Sensing (QS). QS is a communication system between bacteria (fluctuations in the cell population) that determines when the right time is for particular genes to be expressed [8]. QS inhibitors are used to block these virulence processes and different bacterial species like Pseudomonas aeruginosa and Chromobacterium violaceum, with QS-based factors such as exopolysaccharide production, swimming and swarming motility, and the inhibition of violacein production, are used as a models to target bacterial cell-to-cell communication [9].
Fungi are considered important reservoirs of compounds that favor their capacity to grow under different environments and hostile conditions by inhibiting the microbial growth of other organisms [10]. Therefore, the characterization of fungal secondary metabolites with antipathogenic activity is a tool to counteract multidrug resistance [11]. Moreover, these metabolites can also become sources of structural prototypes for chemical modification to prolong the time span of the compound in question in the face of bacterial adaptability [12].
Fungi of the genus Fulvifomes (Hymenochaetaceae) are xylophagous basidiomycetes that cause white rot in trees in tropical deciduous forests, tropical evergreen forests, xerophytic scrublands, and mangroves [13,14,15]. Fulvifomes spp. are characterized by being annual or perennial, pileate, and effusible-to-sub-stipitate; having corky to woody consistency, homogeneous or duplex contexts, hymenophores with circular or angular pores and entire margins, monomitic or dimitic hyphal systems, and the absence of setae; and having subglobose-to-ellipsoidal, yellowish-to-brownish, slightly thick-walled to thick-walled basidiospores [16,17,18]. There have been few reports on the cytotoxic activity of secondary metabolites of Fulvifomes spp. [19,20]. However, there have been no reports on the antibacterial or antipathogenic activity of fungi of this genus. Therefore, this work established the metabolomic profile and antipathogenic capacity of a Fulvifomes specimen isolated from the Sierra de Alamos Natural Protected Area in Sonora, Mexico.

2. Results

2.1. Taxonomy

Basidiomycota, Agaricomycetes, Hymenochaetales, Hymenochaetaceae

  • Fulvifomes mexicanus Mart.-Pineda, R. Valenz. & Raymundo sp. nov.
  • Figure 1: A–I
  • Mycobank: 859269
  • Type. Mexico. Sonora State, Alamos-Río Cuchujaqui Biosphere Reserve, Alamos Municipality, Promontorios, LN 26°59′55″, LW 109°03′21″, alt. 370 m, 26 October 2018, Tropical dry forest, T. Raymundo 8046 (Holotype ENCB).
  • Etymology. mexicanus (Lat.): referring to country of the locality type.
  • Description. Basidiomata 70–135 × 50−70 × 25–55 mm, perennial, pileate-sessile, aplanate with umbo, broadly attached to the substrate, consistency woody hard. Pileus brown (7D-E8) to reddish brown (8E7) with tones dark brown (8F8,4) and the old part of the pileus (center) greyish brown (8F3) to black, concentrically zonate to sulcate, with some lines brownish grey (7E2) to the margin, slightly velvety in younger zones, glabrous, to slightly rimose to cracked, with a distinct crust, up to 5 mm thick to the center. Margin obtuse, sterile to fertile, yellowish brown (5E8), brown (6E8) to dark brown (7F6). Hymenophore poroid, brown (7D7) to dark brown, pores circular, 5–7 per mm, dissepiments (70–) 85–90 (–100) µm thick, and lumen 140–160 µm diam. Tubes brown (7E8), woody hard, up to 45 mm thick, tube layers distinctly stratified with intermittent context layers, individual tube layer up to 3 mm thick. Context up to 10 mm thick, brown (6E8) to dark brown in the surface.
Hyphal system dimitic, tramal hyphae slightly interwoven, with generative hyphae simple septate, hyaline to yellowish in KOH 5%, some light brown, simple to branched, thin walled, 3–5 µm in diam.; skeletal hyphae aseptate, yellowish brown to reddish brown in KOH 5%, unbranched, thick walled, with distinct lumen, 3–6 µm in diam.; contextual hyphae subparallel to slightly interwoven, with generative hyphae simple septate, hyaline, yellowish to light brown in KOH 5%, simple to branched, thin walled, 3–5 µm in diam.; skeletal hyphae dominant, aseptate, yellowish brown to reddish brown in KOH 5%, unbranched, thick walled, with distinct lumen, 4–7 µm in diam. Setae absent in the basidiome. Basidia not observed. Basidiospores 5–6 (−7) × 4–5 µm (average: 5.5 × 4.5, n = 30/1), globose to subglobose in frontal view, broadly ellipsoid to ellipsoid with a plane side in lateral view, (Q = 1–1.15 in frontal view, 1.2–1.5 in lateral view), yellowish brown to reddish Brown in KOH 5%, smooth, thick walled. Habitat. This species grows on live wood of Lysiloma divaricatum (Jacq.) J.F. Macbr. in tropical dry forest and causes a white rot.
Additional specimens examined. Mexico. Sonora State, Alamos-Río Cuchujaqui Biosphere Reserve, Alamos Municipality, Promontorios, LN 26°59′55″, LW 109°03′21″, alt. 370 m, 26 October 2018, Tropical dry forest, M. Martínez-Pineda 5572 (paratype ENCB); R. Valenzuela 18745 (paratype: ENCB).
Remarks. This species is different of the others species of Fulvifomes by its aplanate with umbo, glabrous to cracked and a distinct crust in the basidiomata, its hymenophore with circular pores, 5–7 per mm, its globose basidiospores in frontal view and broadly ellipsoid to ellipsoid with a plane side in lateral view and growing on live wood of Lysiloma divaricatum in tropical dry forest in Mexico.

2.2. Phylogenetic Analysis of Fulvifomes mexicanus sp. nov.

The concatenated alignment of the internal transcribed spacer (nrITS) and large subunit (LSU) of the nuclear ribosomal DNA comprised 29 taxa with 1314 characters including gaps. The three phylogenetic analyses, maximum parsimony (MP), maximum likelihood (ML), and Bayesian Inference (BI) of the dataset recovered similar topologies (Figure 1J). No significant conflict (bootstrap value > 80%) was detected among the topologies obtained by the different analyses. The MP analysis of the alignment found 958 trees of 141 steps (CI = 0.1001, HI = 0.1007, RI = 0.2561, RC = 0.1830). The best ML tree with a final likelihood value of –18230.008340 was presented. The matrix had 852 distinct alignment patterns, with 3.05% undetermined characters or gaps. Estimated base frequencies were as follows: A = 0.100831, C = 0.101834, G = 0.183504, and T = 0.186420; substitution rates: AC = 1.000814, AG = 1.000972, AT = 1.008648, CG = 1.903712, CT = 4.620044, and GT = 1.1000000; the gamma distribution shape parameter α = 0.000265. The BI analysis showed a standard deviation between the chains stabilized at 0.001 after 3.5 million generations. No significant changes in tree topology configuration or cumulative split frequencies of selected nodes were observed after about 0.35 million generations, which were discarded as 25% burn-in. The analysis produced a phylogenetic tree where Fulvifomes mexicanus was shown as a monophyletic group (BS = 100%, BS = 100%, BI p = 1). Sequences are available in GenBank under the accession numbers PV522025-PV522027 (ITS) and PV563098-PV563100 (LSU).
Figure 1. Basidiomata of the type specimens examined (AI) and phylogenetic reconstruction based on the ITS and LSU regions (J). MP and BI analyses recovered identical topologies concerning the relationships among the main clades of Fulvifomes members. For each node, the following values have been provided: MP (≥70%, left)/ML bootstrap (≥70%, middle) and the BI posterior probability (≥0.85, right). The scale bar represents the expected number of nucleotide substitutions per site.
Figure 1. Basidiomata of the type specimens examined (AI) and phylogenetic reconstruction based on the ITS and LSU regions (J). MP and BI analyses recovered identical topologies concerning the relationships among the main clades of Fulvifomes members. For each node, the following values have been provided: MP (≥70%, left)/ML bootstrap (≥70%, middle) and the BI posterior probability (≥0.85, right). The scale bar represents the expected number of nucleotide substitutions per site.
Molecules 30 02278 g001

2.3. Antimicrobial Activity and Inhibition of Swimming Motility

The methanolic extract of Fulvifomes mexicanus sp. nov. showed antibacterial activity against Staphylococcus aureus and Vibrio parahaemolyticus with a minimum inhibitory concentration (MIC) of 2.3 mg/mL and Chromobacterium violaceum with an MIC of 4.7 mg/mL. The least susceptible bacteria to this extract were the pathogens Salmonella typhimurium and Pseudomonas aeruginosa with MIC values of 9.4 and 18.8 mg/mL, respectively. No activity was observed for the chloroform extract of the fungus.
Based on the latter, the impact on swimming-type bacterial motility was established only for the fungus’s methanolic extract against S. typhimurium ATCC 7251 and P. aeruginosa ATCC 9027 at concentrations of 1/16 and 1/32 MIC. Interestingly, the methanolic extract inhibited the motility of P. aeruginosa by approximately 30% while no effect was observed on the motility of S. typhimurium (Figure 2). These data are important because the anti-motility compounds were aimed at specific targets as the mobility between the two types of bacteria was different.

2.4. Inhibition of Violacein Production

The effect of the methanolic extract of F. mexicanus sp. nov. on the Quorum sensing (QS) of C. violaceum was evaluated by reducing the production of violacein at sub-MIC concentrations. The results showed that the extract reduced the violacein concentrations at 1/8 and 1/16 of the MIC by 68.6% and 17.8%, respectively (Figure 3).

2.5. Metabolomic Profiling and Molecular Networking

The untargeted metabolomic analysis of the fungal methanolic extract was performed using LC-HRESIMS-MS/MS data and the global natural product social molecular networking (GNPS) platform. Metabolites in the extract were grouped into two-hundred-and-ninety-eight nodes, forming 12 clusters with at least three nodes, 12 with two nodes, and 194 singletons. From this, 4% of the nodes were associated with linoleic acid and derivatives, 0.4% were identified as phosphate esters, and 95% were not assigned to any chemical subclass (Figure 4 and Table 1). To expand the library of metabolites annotated by molecular networking, accurate mass values, MS/MS fragment ions, and UV data were used to identify metabolites manually by comparison with the literature data and information available at the Dictionary of Natural Products (https://dnp.chemnetbase.com, accessed on 28 February 2025). To perform the presumptive identification, those from the Hymenochaetaceae family with a reported MS2 spectrum, at least four ions matching, and similar fragmentation patterns from predictor CFM-ID 4.0 were used as the reference. From this analysis, 11 additional metabolites were annotated, including a pyrone, a sesquiterpenoid, and hispidine derivates (Table 2).

3. Discussion

Bacterial infection control has been limited by the emergence of multidrug-resistant strains [1,21]. An alternative to counteract this problem is to identify and isolate compounds that attenuate the virulence of pathogenic microorganisms [22]. The disruption of Quorum sensing (QS) and bacterial motility is proposed as a way to fight infection by modulating bacterial pathogenicity and weakening the pathogen against the immune system [23].
Fungi of the Hymenochaetaceae family have been used in traditional medicine to treat, among others, several types of infections [24,25]. Fulvifomes mexicaus sp. nov. is a species characterized by the formation of ungulate basidiomata with reddish-brown spores growing on living trees of Lysiloma latisiquum. These characteristics, together with phylogenetic analysis, clearly distinguish it from other species of the genus. This work has shown the methanolic extract’s biological activity and metabolomic profile from the F. mexicanus sp. nov. basidiome. The methanolic extract reduced the motility of P. aeruginosa ATCC 9027. This bacterium exhibits a flagellum-dependent swimming motility, which plays an important role in its movement during the infection process, as well as in the formation of biofilm, which contributes to antibiotic resistance [26,27,28,29,30,31,32]. The extract did not restrict the swimming motility of S. typhimurium ATCC 7251, which is relevant since anti-motility compounds aim at specific targets. The decrease in motility in P. aeruginosa ATCC 9027 could have been related to the presence of ergosterol peroxide, a terpenoid compound associated with the inhibition of the assembly of motility structures due to its interaction with the bacterial membrane and cytoplasm [33]. A wide range of biological actions have also been attributed to this compound, including antioxidant, antimicrobial, antiparasitic, antiviral, antifungal, cytotoxic and immunomodulatory activities [34,35,36,37,38,39].
QS regulates the expression of virulence genes, and its inhibition is therefore considered an alternative to antibiotics to avoid the development of bacterial resistance [40,41]. The methanolic extract inhibited violacein production by up to 70%. Previous reports showed that basidiomycetes of the genus Phellinus (Hymenochaetaceae) reduced violacein production by C. violaceum CV026 [42,43]. The reduction in violacein production is mainly caused by analogs of autoinducers, phenols, flavonoids, furanones, terpenoids, alkylglycerols, pyrones, and γ-butyrolactones with AHL-like structures or their reactive groups capable of interacting with the target site, which have been associated with the inhibition of pigment synthesis [44,45,46,47,48,49,50]. Many of these compounds were identified in the metabolic profile of F. mexicanus sp. nov. It is imperative to acknowledge that the biological activities were evaluated using crude extracts. Consequently, the presence of combined or pure compounds may have contributed to the observed biological activities. On the other hand, if the observed effect on QS was due to a single component in the extract, its activity in pure form would probably have been much higher, making very interesting its isolation and characterization.
The metabolomic profile of species belonging to the genus Phellinus sensu lato, from which the genus Fulvifomes was segregated, has been described by several authors [51]. These species concur on the presence of alkaloids, tannins, flavonoids, steroids, glycosides, and phenolic compounds, which are associated with a variety of biological activities [52,53,54]. For example, the methanolic extracts of Fuscoporia ferruginosa, Inonotus hispidus, and Phenillus spp. contain polyphenols with antioxidant activity and could also be responsible for their antibacterial activity [55,56,57]. Nevertheless, this was the first study in which the identification and characterization of the compounds of the Fulvifomes genus was performed.
The Fulvifomes mexicanus sp. nov. methanolic extract revealed the presence of various hispidin-derived compounds such as interfungin A, 10-O-Methylinoscavin C, phellibaumin D, phelligridin I, and inoscavin types A, C, and E, which have shown a range of biological activities, including antioxidant, antibacterial, antitumoral, cytotoxic, and antiviral activities. The generation of these compounds is facilitated by the oxidative coupling of hispidin with additional phenolic compounds or other hispidins, a process catalyzed by peroxidases [58,59,60]. Lipid compounds, such as linoleic acid, a metabolite present in cell membranes, were also abundant in the extract. The lipid derivatives have been implicated in the growth and development of the fruiting bodies of various fungi [61,62]. Additionally, clusters of unidentified metabolites, devoid of any chemical classification, suggests their potential as subjects for further study, with the possibility of yielding novel chemical entities.

4. Materials and Methods

4.1. Fungal Specimen

The specimen was collected in the Sierra de Alamos Natural Protected Area, Sonora, Mexico and preserved at the Herbarium of the National School of Biological Sciences of the National Polytechnic Institute, with access code TR5566. The identification and characterization of the fungus was carried out according to the guidelines of Dai [63] and Gilbertson and Ryvarden [64]. The size, shape, color, consistency, texture of the basidiome, and the shapes and sizes of the pores were analyzed. The Kornerup and Wanscher [65] table was used to establish the colors of the structures. Sections were made to describe micromorphological characters, including spores, basidia, cystidia, hyphal system, and hymenophores [66]. The species was confirmed by sequence analysis of the internal transcribed spacer of the nuclear ribosomal DNA (nrITS) [67].

4.2. Genetic Identification

Genomic DNA was extracted from 50–100 mg of the basidiome using the CTAB method [68]. The process of the internal transcribed spacer of the nuclear ribosomal DNA (nrITS) and large subunit (LSU) amplification were carried out [69]. The PCR products were purified with the ExoSAP Purification kit (Affymetrix, Cleveland, OH, USA) following the manufacturer’s instructions. Amplicons were quantified and sequenced with an Applied Biosystem model 3730XL (Applied BioSystems, Foster City, CA, USA). Subsequently, the sequences were analyzed, edited, and assembled using the BioEdit v7.0.1 [70] to generate a consensus sequence.
In order to study phylogenetic relationships, the consensus sequences were compared with those deposited in the GenBank of the National Center for Biotechnology Information (NCBI) using the tool BLAST v2.2.19 [71]. The ITS and LSU regions were aligned using the online version of MAFFT v7 [72]. The alignments were revised with PhyDE v0.9971 [73] followed by minor manual adjustments to ensure character homology between taxa. The data were analyzed using maximum parsimony (MP), maximum likelihood (ML), and Bayesian Inference (BI). MP analysis was carried out in PAUP* 4.0b10 [74] using the heuristic search mode, 1000 random starting replicates, and TBR branch swapping, with MULTREES and Collapse on. Bootstrap values were estimated using 1000 replicates under the heuristic search mode, each with 100 random starting replicates. ML analysis was carried out in IQ-tree v1.6.12 [75] with a GTR + G model of nucleotide substitution. To assess branch support, 1000 rapid bootstrap replicates were run with the GTRGAMMA model. BI was carried out in MrBayes v3.2.7 [76] with four chains and the best evolutionary model for alignment was sought using Partition Finder [77]. The matrix included two simultaneous runs of Montecarlo chains, with temperature set to 0.2 and sampling 10 million generations (standard deviation ≤ 0.1). Chain convergence was visualized with TRACER v1.7.1 [78]. The remaining trees were used to calculate a 50% majority-rule consensus topology and posterior probabilities (PP). Trees were visualized and optimized in FigTree v1.4.4 [79].

4.3. Extracts Preparation

The fungus’s fruiting bodies were washed with distilled water, dried at 42 °C, and ground into powder. Thirty grams of the powder were mixed with 300 mL of methanol or chloroform (Meyer, CDMX, Mexico). Each mixture was incubated at room temperature for a period of four days, shaking constantly. Subsequently, each mixture was filtered and concentrated under reduced pressure. Dried extracts were dissolved in hexane (Meyer, CDMX, Mexico), evaporated to a completely dry solid, and kept at 4 °C until use.

4.4. Antimicrobial Activity and Minimum Inhibitory Concentration (MIC).

The extracts were tested for antibacterial activity against Salmonella typhimurium ATCC 7251, Pseudomonas aeruginosa ATCC 9027, Vibrio parahaemolyticus (clinical isolate), and Staphylococcus aureus (clinical isolate). All pathogens were cultured in Mueller–Hinton (MH) broth (Difco, Sparks, MD, USA) for 24 h at 37 °C, adjusted to 0.5 on the McFarland scale, and spread onto MH agar plates using a sterile swab. After drying, 10 µL of each fungal extract (37.5 mg of extract in 1:1 DMSO-H2O) was dropped onto the plate, on a sterile filter paper disk. Chloramphenicol (Sigma-Aldrich, St. Louis, MO, USA) disks (30 µg/mL) was used as antibacterial activity control and 1:1 DMSO-H2O as solvent control. Plates were incubated for 24 h at 37 °C. Assays were performed in triplicate [80,81]. In addition, the minimum inhibitory concentration (MIC) of the fungal extracts was established using the broth microdilution method in 96-well microtiter plates, following the protocol of the Clinical and Laboratory Standards Institute (CLSI) [82].

4.5. Mobility Inhibition Tests

Salmonella typhimurium ATCC 7251 and P. aeruginosa ATCC 9027 were used to perform swimming motility assays. The growth curves for each pathogen were determined in the presence of extracts diluted to 1/4, 1/8, 1/16, and 1/32 of the MIC. Semi-solid Luria Broth (LB) (0.2% agar) medium plates supplemented with the extracts were used for the motility assay. Plates were inoculated with 5 µL of culture adjusted to 0.1 optical density at 600 nm (OD600). The radial growth diameter was measured after incubation of the plates at 30 °C for 36 h [83].

4.6. Inhibition of Violacein Production.

Chromobacterium violaceum CV026 was used to evaluate the effect of the extracts on QS [84]. First, the growth curve was established with the extract diluted to 1/8, 1/16, and 1/32 of the MIC. The strain CV026 was inoculated in LB medium (Difco, MD, USA) to 0.1 OD600. Then, the culture was supplemented with N-hexanoyl-L-homoserine lactone (C6-AHL) (Sigma-Aldrich, St. Louis, MO, USA) at a final concentration of 50 μM. Subsequently, the extracts were diluted until 1/16 and 1/32 of the MIC was reached. DMSO (final concentration 2.4%) and C6-AHL without extracts were used as controls. Tubes were incubated at 32 °C for 16 h with continuous shaking at 200 rpm. Upon completion of the incubation time, cell density was determined by absorbance at 720 nm by using the LB medium as a blank. Finally, the production of violacein was measured. Briefly, 500 μL of the bacterial culture was placed in a 2 mL tube, and then, 500 μL of acetone was added. The tubes were vortexed and centrifuged at 15,000 rpm for 1 min, and the supernatants were separated. The specific production of violacein was calculated by dividing the value of the reading at 577 nm by that at 720 nm. Each experiment was performed 3 times.

4.7. LC-MS, Untargeted Metabolomic and Feature-Based Molecular Network Analysis

Extracts (1 mg/mL) were analyzed on an Acquity UPLC (Waters Corp., Milford, MA, USA) coupled to a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). LC analysis was performed on an Acquity BEH C18 column (130 Å, 1.7 µm, 2.1 mm × 50 mm; Waters) at 40 °C, with a gradient system from 15:85 CH3CN–0.1% aqueous formic acid to 100% of CH3CN in 8 min, then held for 1.5 min with CH3CN and returned to the starting conditions. The flow rate was 0.3 mL/min, and the injection volume was 3.0 µL. HRMS-MS/MS data were obtained using an ESI source with positive and negative modes at a full scan range (m/z 150–2000), with the top 5 MSn collected during the whole run. The following settings were used for the MS system: capillary voltage, 5 V; capillary temperature, 300 C; tube lens offset, 35 V; spray voltage, 3.80 kV; sheath and auxiliary gas flow, 30 arbitrary units [85]. Then, MS data were converted to mzXML format using MS Converter tool (ProteoWizard v3.0). A molecular network was created with the Feature-Based Molecular Networking (FBMN) workflow [86] on GNPS (https://gnps.ucsd.edu, accessed on 28 February 2025, [87]). The MS data were first processed with MZmine v3.3.0 [88] and the results were exported to GNPS for FBMN analysis. The spectra in the network were then searched automatically against GNPS spectral libraries [87,89]. The DEREPLICATOR, MS2LDA, and MolNetEnhancer were used to annotate MS/MS-spectrum chemical classification [3,86,90]. The molecular networks were visualized using Cytoscape v3.9.1 [91]. Additionally, manual dereplication was assessed by comparison of HRMS-MS/MS data with those reported in the Dictionary of Natural Products. The manual annotation was made at confidence levels 1 and 2, respectively, according to the metabolomics standards initiative and exact mass accuracy < 5 ppm [92].

4.8. Statistical Analysis

GraphPad Prism software v9.5.1 was used to analyze the data using analysis of variance (ANOVA) (α = 0.05). To calculate statistically significant difference values, Dunnett’s test was used for comparisons of means with the control (p < 0.05) [93].

5. Conclusions

This work represented the first study of the antipathogenic properties of a fungus of the Fulvifomes genus. The metabolomic profile of the new species Fulvifomes mexicanus sp. nov., which is mainly composed of hispidine derivatives, had not been previously described in this genus and could explain the activity observed in the methanolic extract. Overall, the remarkable chemical diversity detected underscores the potential of F. mexicanus as a source of pharmacologically active molecules useful for the development of novel antimicrobial agents.

Author Contributions

A.B.-N. and M.M.-P. performed experiments and investigation; M.F., A.D.P. and R.V.-S. conducted the metabolomics analysis; A.P.-V. and E.C.-Q. conducted microbial assays; T.R., C.R.M.-G. and R.V. conducted the fungus identification; A.P.-V. and T.R. managed the writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by (1) The Secretaría de Investigación y Posgrado del Instituto Politécnico Nacional (SIP grants 20250567, 20251037, 20240029, 20240367, and 20240043) and (2) DGAPA-PAPIIT-UNAM IN203923. A.B.N. holds a scholarship from CONAHCyT and BEIFI. E.C.-Q. and R.V. are COFAA, EDI, and SNI recipients. T.R. and A.P.-V. are EDI and SNI recipients. M.F. is an SNI and DGAPA recipient.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Acknowledgments

We thank Mariano Jacome-Rebollo and Ramiro del Carmen from FQ, UNAM for their support during the molecular networking analysis and computational resources.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations have been used in this manuscript:
LC-HRESIMSLiquid Chromatography–High-Resolution Electrospray Ionization Mass Spectrometry
QSQuorum Sensing
nrITSInternal Transcribed Spacer of the nuclear ribosomal DNA
MICMinimum Inhibitory Concentration
GNPSGlobal Natural Product Social Molecular Networking
MSMass Spectrometry
MPMaximum Parsimony
MLMaximum Likelihood
BIBayesian Inference
MICMinimum Inhibitory Concentration
CLSIClinical and Laboratory Standards Institute
MHMueller–Hinton
LBLuria Broth
C6-AHLN-hexanoyl-L-homoserine lactone
FBMNFeature-Based Molecular Networking

References

  1. Tang, K.W.K.; Millar, B.C.; Moore, J.E. Antimicrobial Resistance (AMR). Br. J. Biomed. Sci. 2023, 80, 11387. [Google Scholar] [CrossRef] [PubMed]
  2. Djordjevic, S.P.; Jarocki, V.M.; Seemann, T.; Cummins, M.L.; Watt, A.E.; Drigo, B.; Wyrsch, E.R.; Reid, C.J.; Donner, E.; Howden, B.P. Genomic Surveillance for Antimicrobial Resistance—A One Health Perspective. Nat. Rev. Genet. 2024, 25, 142–157. [Google Scholar] [CrossRef] [PubMed]
  3. Ernst, M.; Kang, K.B.; Caraballo-Rodríguez, A.M.; Nothias, L.-F.; Wandy, J.; Chen, C.; Wang, M.; Rogers, S.; Medema, M.H.; Dorrestein, P.C.; et al. MolNetEnhancer: Enhanced Molecular Networks by Integrating Metabolome Mining and Annotation Tools. Metabolites 2019, 9, 144. [Google Scholar] [CrossRef]
  4. Escaich, S. Antivirulence as a New Antibacterial Approach for Chemotherapy. Curr. Opin. Chem. Biol. 2008, 12, 400–408. [Google Scholar] [CrossRef]
  5. Escaich, S. Novel Agents to Inhibit Microbial Virulence and Pathogenicity. Expert Opin. Ther. Pat. 2010, 20, 1401–1418. [Google Scholar] [CrossRef] [PubMed]
  6. Hashem, A.H.; Attia, M.S.; Kandil, E.K.; Fawzi, M.M.; Abdelrahman, A.S.; Khader, M.S.; Khodaira, M.A.; Emam, A.E.; Goma, M.A.; Abdelaziz, A.M. Bioactive Compounds and Biomedical Applications of Endophytic Fungi: A Recent Review. Microb. Cell Fact. 2023, 22, 107. [Google Scholar] [CrossRef]
  7. Liao, C.; Huang, X.; Wang, Q.; Yao, D.; Lu, W. Virulence Factors of Pseudomonas aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance. Front. Cell. Infect. Microbiol. 2022, 12, 926758. [Google Scholar] [CrossRef]
  8. Wang, Y.; Bian, Z.; Wang, Y. Biofilm Formation and Inhibition Mediated by Bacterial Quorum Sensing. Appl. Microbiol. Biotechnol. 2022, 106, 6365–6381. [Google Scholar] [CrossRef]
  9. Fuentes-Gutiérrez, A.; Curiel-Quesada, E.; Correa-Basurto, J.; Martínez-Muñoz, A.; Reyes-Arellano, A. N-Heterocycles Scaffolds as Quorum Sensing Inhibitors. Design, Synthesis, Biological and Docking Studies. Int. J. Mol. Sci. 2020, 21, 9512. [Google Scholar] [CrossRef]
  10. Conrado, R.; Gomes, T.C.; Roque, G.S.C.; De Souza, A.O. Overview of Bioactive Fungal Secondary Metabolites: Cytotoxic and Antimicrobial Compounds. Antibiotics 2022, 11, 1604. [Google Scholar] [CrossRef]
  11. Buroni, S.; Chiarelli, L.R. Antivirulence Compounds: A Future Direction to Overcome Antibiotic Resistance? Future Microbiol. 2020, 15, 299–301. [Google Scholar] [CrossRef] [PubMed]
  12. Walsh, C.T.; Wencewicz, T.A. Prospects for New Antibiotics: A Molecule-Centered Perspective. J. Antibiot. 2014, 67, 7–22. [Google Scholar] [CrossRef] [PubMed]
  13. Du, P.; Cao, T.-X.; Wu, Y.-D.; Zhou, M.; Liu, Z.-B. Two New Species of Hymenochaetaceae on Dracaena cambodiana from Tropical China. MycoKeys 2021, 80, 1–17. [Google Scholar] [CrossRef]
  14. Isaka, M.; Palasarn, S.; Sakayaroj, J.; Srichomthong, K.; Nithithanasilp, S.; Sappan, M. Limonoids from Fruiting Bodies of the Wood-Rot Basidiomycete Fulvifomes xylocarpicola Associated with the Mangrove Tree Xylocarpus granatum. Phytochemistry 2021, 181, 112555. [Google Scholar] [CrossRef]
  15. Schwarze, F.W.M.R.; Engels, J.; Mattheck, C. Host-Fungus Interactions: Development and Prognosis of Wood Decay in the Sapwood. In Fungal Strategies of Wood Decay in Trees; Springer: Berlin/Heidelberg, Germany, 2000; pp. 139–167. ISBN 978-3-642-63133-7. [Google Scholar]
  16. Hattori, T.; Ota, Y.; Sotome, K. Two New Species of Fulvifomes (Basidiomycota, Hymenochaetaceae) on Threatened or near Threatened Tree Species in Japan. Mycoscience 2022, 63, 131–141. [Google Scholar] [CrossRef]
  17. Suh, H.; Cho, Y.; Seo, C.W.; Kim, D.; Lee, H.-S.; Lim, Y.W. A Taxonomic Study of Fulvifomes (Hymenochaetales, Basidiomycota) in the Federated States of Micronesia and Identification of Two New Species. Mycol. Prog. 2024, 23, 15. [Google Scholar] [CrossRef]
  18. Wu, F.; Zhou, L.-W.; Vlasák, J.; Dai, Y.-C. Global Diversity and Systematics of Hymenochaetaceae with Poroid Hymenophore. Fungal Divers. 2022, 113, 1–192. [Google Scholar] [CrossRef]
  19. Fernando, D.; Adhikari, A.; Nanayakkara, C.; De Silva, E.D.; Wijesundera, R.; Soysa, P. Cytotoxic Effects of Ergone, a Compound Isolated from Fulviformes fastuosus. BMC Complement. Altern. Med. 2016, 16, 484. [Google Scholar] [CrossRef] [PubMed]
  20. Govindharaj, M.; Arumugam, S.; Nirmala, G.; Bharadwaj, M.; Murugiyan, K. Effect of Marine Basidiomycetes Fulvifomes sp. Derived Ergosterol Peroxide on Cytotoxicity and Apoptosis Induction in MCF-7 Cell Line. J. Fungi 2019, 5, 16. [Google Scholar] [CrossRef]
  21. Aslam, B.; Khurshid, M.; Arshad, M.I.; Muzammil, S.; Rasool, M.; Yasmeen, N.; Shah, T.; Chaudhry, T.H.; Rasool, M.H.; Shahid, A.; et al. Antibiotic Resistance: One Health One World Outlook. Front. Cell. Infect. Microbiol. 2021, 11, 771510. [Google Scholar] [CrossRef]
  22. Tacconelli, E.; Carrara, E.; Savoldi, A.; Harbarth, S.; Mendelson, M.; Monnet, D.L.; Pulcini, C.; Kahlmeter, G.; Kluytmans, J.; Carmeli, Y.; et al. Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. Lancet Infect. Dis. 2018, 18, 318–327. [Google Scholar] [CrossRef] [PubMed]
  23. LaSarre, B.; Federle, M.J. Exploiting Quorum Sensing to Confuse Bacterial Pathogens. Microbiol. Mol. Biol. Rev. 2013, 77, 73–111. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, X.; Wei, J.; Liu, Z.; Wang, Y.; Yuan, X.; Wang, D.; Niu, J.; Yang, Y.; Zhou, J. Comparative Genomic Analysis of Sanghuangporus sanghuang with Other Hymenochaetaceae Species. Braz. J. Microbiol. 2024, 55, 87–100. [Google Scholar] [CrossRef] [PubMed]
  25. Zheng, W.; Miao, K.; Liu, Y.; Zhao, Y.; Zhang, M.; Pan, S.; Dai, Y. Chemical Diversity of Biologically Active Metabolites in the Sclerotia of Inonotus obliquus and Submerged Culture Strategies for Up-Regulating Their Production. Appl. Microbiol. Biotechnol. 2010, 87, 1237–1254. [Google Scholar] [CrossRef]
  26. Chaban, B.; Hughes, H.V.; Beeby, M. The Flagellum in Bacterial Pathogens: For Motility and a Whole Lot More. Semin. Cell Dev. Biol. 2015, 46, 91–103. [Google Scholar] [CrossRef]
  27. Conrad, J.C.; Gibiansky, M.L.; Jin, F.; Gordon, V.D.; Motto, D.A.; Mathewson, M.A.; Stopka, W.G.; Zelasko, D.C.; Shrout, J.D.; Wong, G.C.L. Flagella and Pili-Mediated Near-Surface Single-Cell Motility Mechanisms in P. aeruginosa. Biophys. J. 2011, 100, 1608–1616. [Google Scholar] [CrossRef]
  28. De La Fuente-Núñez, C.; Korolik, V.; Bains, M.; Nguyen, U.; Breidenstein, E.B.M.; Horsman, S.; Lewenza, S.; Burrows, L.; Hancock, R.E.W. Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide. Antimicrob. Agents Chemother. 2012, 56, 2696–2704. [Google Scholar] [CrossRef]
  29. Jarrell, K.F.; McBride, M.J. The Surprisingly Diverse Ways That Prokaryotes Move. Nat. Rev. Microbiol. 2008, 6, 466–476. [Google Scholar] [CrossRef]
  30. Khan, F.; Pham, D.T.N.; Oloketuyi, S.F.; Kim, Y.-M. Regulation and Controlling the Motility Properties of Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 2020, 104, 33–49. [Google Scholar] [CrossRef]
  31. O’Toole, G.A.; Kolter, R. Flagellar and Twitching Motility Are Necessary for Pseudomonas aeruginosa Biofilm Development. Mol. Microbiol. 1998, 30, 295–304. [Google Scholar] [CrossRef]
  32. Yeung, A.T.Y.; Torfs, E.C.W.; Jamshidi, F.; Bains, M.; Wiegand, I.; Hancock, R.E.W.; Overhage, J. Swarming of Pseudomonas aeruginosa Is Controlled by a Broad Spectrum of Transcriptional Regulators, Including MetR. J. Bacteriol. 2009, 191, 5592–5602. [Google Scholar] [CrossRef] [PubMed]
  33. Di Pasqua, R.; Betts, G.; Hoskins, N.; Edwards, M.; Ercolini, D.; Mauriello, G. Membrane Toxicity of Antimicrobial Compounds from Essential Oils. J. Agric. Food Chem. 2007, 55, 4863–4870. [Google Scholar] [CrossRef] [PubMed]
  34. Duan, C.; Ge, X.; Wang, J.; Wei, Z.; Feng, W.; Wang, J. Ergosterol Peroxide Exhibits Antiviral and Immunomodulatory Abilities against Porcine Deltacoronavirus (PDCoV) via Suppression of NF-κB and P38/MAPK Signaling Pathways in vitro. Int. Immunopharmacol. 2021, 93, 107317. [Google Scholar] [CrossRef] [PubMed]
  35. Liu, Y.; Wang, X.; Wang, J.; Zhang, J.; Duan, C.; Wang, J. Ergosterol Peroxide Inhibits Porcine Epidemic Diarrhea Virus Infection in Vero Cells by Suppressing ROS Generation and P53 Activation. Viruses 2022, 14, 402. [Google Scholar] [CrossRef]
  36. Merdivan, S.; Lindequist, U. Ergosterol Peroxide: A Mushroom-Derived Compound with Promising Biological Activities-A Review. Int. J. Med. Mushrooms 2017, 19, 93–105. [Google Scholar] [CrossRef]
  37. Meza-Menchaca, T.; Ramos-Ligonio, A.; López-Monteon, A.; Vidal Limón, A.; Kaluzhskiy, L.A.; Shkel, T.V.; Strushkevich, N.V.; Jiménez-García, L.F.; Agredano Moreno, L.T.; Gallegos-García, V.; et al. Insights into Ergosterol Peroxide’s Trypanocidal Activity. Biomolecules 2019, 9, 484. [Google Scholar] [CrossRef]
  38. Wang, F.-W. Bioactive Metabolites from Guignardia sp., an Endophytic Fungus Residing in Undaria Pinnatifida. Chin. J. Nat. Med. 2012, 10, 72–76. [Google Scholar] [CrossRef]
  39. Zhou, B.; Liang, X.; Feng, Q.; Li, J.; Pan, X.; Xie, P.; Jiang, Z.; Yang, Z. Ergosterol Peroxide Suppresses Influenza A Virus-Induced pro-Inflammatory Response and Apoptosis by Blocking RIG-I Signaling. Eur. J. Pharmacol. 2019, 860, 172543. [Google Scholar] [CrossRef]
  40. Durán, N.; Justo, G.Z.; Durán, M.; Brocchi, M.; Cordi, L.; Tasic, L.; Castro, G.R.; Nakazato, G. Advances in Chromobacterium violaceum and Properties of Violacein-Its Main Secondary Metabolite: A Review. Biotechnol. Adv. 2016, 34, 1030–1045. [Google Scholar] [CrossRef]
  41. Koh, C.-L.; Sam, C.-K.; Yin, W.-F.; Tan, L.; Krishnan, T.; Chong, Y.; Chan, K.-G. Plant-Derived Natural Products as Sources of Anti-Quorum Sensing Compounds. Sensors 2013, 13, 6217–6228. [Google Scholar] [CrossRef]
  42. Zhu, H.; Wang, S.; Zhang, S.; Cao, C. Inhibiting Effect of Bioactive Metabolites Produced by Mushroom Cultivation on Bacterial Quorum Sensing-Regulated Behaviors. Chemotherapy 2011, 57, 292–297. [Google Scholar] [CrossRef] [PubMed]
  43. Zhu, H.; Liu, W.; Wang, S.; Tian, B.; Zhang, S. Evaluation of Anti-Quorum-Sensing Activity of Fermentation Metabolites from Different Strains of a Medicinal Mushroom, Phellinus igniarius. Chemotherapy 2012, 58, 195–199. [Google Scholar] [CrossRef] [PubMed]
  44. Chaverra Daza, K.E.; Silva Gómez, E.; Moreno Murillo, B.D.; Mayorga Wandurraga, H. Natural and Enantiopure Alkylglycerols as Antibiofilms Against Clinical Bacterial Isolates and Quorum Sensing Inhibitors of Chromobacterium violaceum ATCC 12472. Antibiotics 2021, 10, 430. [Google Scholar] [CrossRef] [PubMed]
  45. Grabski, H.; Hunanyan, L.; Tiratsuyan, S.; Vardapetyan, H. Interaction of Quercetin with Transcriptional Regulator LasR of Pseudomonas aeruginosa: Mechanistic Insights of the Inhibition of Virulence through Quorum Sensing. bioRxiv 2017. [Google Scholar] [CrossRef]
  46. Hernando-Amado, S.; Alcalde-Rico, M.; Gil-Gil, T.; Valverde, J.R.; Martínez, J.L. Naringenin Inhibition of the Pseudomonas aeruginosa Quorum Sensing Response Is Based on Its Time-Dependent Competition With N-(3-Oxo-Dodecanoyl)-L-Homoserine Lactone for LasR Binding. Front. Mol. Biosci. 2020, 7, 25. [Google Scholar] [CrossRef]
  47. Manefield, M.; De Nys, R.; Naresh, K.; Roger, R.; Givskov, M.; Peter, S.; Kjelleberg, S. Evidence That Halogenated Furanones from Delisea Pulchra Inhibit Acylated Homoserine Lactone (AHL)-Mediated Gene Expression by Displacing the AHL Signal from Its Receptor Protein. Microbiology 1999, 145, 283–291. [Google Scholar] [CrossRef]
  48. Santos, C.A.; Lima, E.M.F.; Franco, B.D.G.D.M.; Pinto, U.M. Exploring Phenolic Compounds as Quorum Sensing Inhibitors in Foodborne Bacteria. Front. Microbiol. 2021, 12, 735931. [Google Scholar] [CrossRef]
  49. Shi, R.; Luo, Q.; Liu, Y.; Meng, G.; Chen, W.; Wang, C. Effect of γ-Butyrolactone, a Quorum Sensing Molecule, on Morphology and Secondary Metabolism in Monascus. LWT 2022, 172, 114225. [Google Scholar] [CrossRef]
  50. Wang, W.; Li, D.; Huang, X.; Yang, H.; Qiu, Z.; Zou, L.; Liang, Q.; Shi, Y.; Wu, Y.; Wu, S.; et al. Study on Antibacterial and Quorum-Sensing Inhibition Activities of Cinnamomum camphora Leaf Essential Oil. Molecules 2019, 24, 3792. [Google Scholar] [CrossRef]
  51. Wu, C.-S.; Lin, Z.-M.; Wang, L.-N.; Guo, D.-X.; Wang, S.-Q.; Liu, Y.-Q.; Yuan, H.-Q.; Lou, H.-X. Phenolic Compounds with NF-κB Inhibitory Effects from the Fungus Phellinus baumii. Bioorganic Med. Chem. Lett. 2011, 21, 3261–3267. [Google Scholar] [CrossRef]
  52. Kodiyalmath, J.K.; Krishnappa, M. Evaluation of Antimicrobial Activity of Phellinus linteus (Berk. & M.A Curtis.) with Their Wild Collections from Western Ghats of India. Trop. Plant Res. 2017, 4, 351–357. [Google Scholar] [CrossRef]
  53. Ayala-Zavala, J.F.; Silva-Espinoza, B.A.; Cruz-Valenzuela, M.R.; Villegas-Ochoa, M.A.; Esqueda, M.; González-Aguilar, G.A.; Calderón-López, Y. Antioxidant and Antifungal Potential of Methanol Extracts of Phellinus spp. from Sonora, Mexico. Rev. Iberoam. Micol. 2012, 29, 132–138. [Google Scholar] [CrossRef] [PubMed]
  54. Yoon, K.-N.; Jang, H.S. Antioxidant and Antimicrobial Activities of Fruiting Bodies of Phellinus gilvus Collected in Korea. Korean J. Clin. Lab. Sci. 2016, 48, 355–364. [Google Scholar] [CrossRef]
  55. Contato, A.G.; De Araújo, C.A.V.; Zanzarin, D.M.; Aranha, G.M.; Sybuia, P.A.; Pilau, E.J.; Castoldi, R.; Peralta, R.M.; De Souza, C.G.M. Biological Characterization and Antimicrobial Bioactives of Mycelium Extracts from Medicinal Mushrooms Phellinus linteus and Pleurotus albidus (Agaricomycetes). Int. J. Med. Mushrooms 2022, 24, 47–55. [Google Scholar] [CrossRef]
  56. Dokhaharani, S.C.; Ghobad-Nejhad, M.; Moghimi, H.; Farazmand, A.; Rahmani, H. Biological Activities of Two Polypore Macrofungi (Basidiomycota) and Characterization of Their Compounds Using HPLC–DAD and LC–ESI–MS/MS. Folia Microbiol. 2021, 66, 775–786. [Google Scholar] [CrossRef] [PubMed]
  57. Smolskaitė, L.; Venskutonis, P.R.; Talou, T. Comprehensive Evaluation of Antioxidant and Antimicrobial Properties of Different Mushroom Species. LWT Food Sci. Technol. 2015, 60, 462–471. [Google Scholar] [CrossRef]
  58. Lee, I.-K.; Yun, B.-S. Hispidin Analogs from the Mushroom Inonotus xeranticus and Their Free Radical Scavenging Activity. Bioorganic Med. Chem. Lett. 2006, 16, 2376–2379. [Google Scholar] [CrossRef]
  59. Lee, I.-K.; Seok, S.-J.; Kim, W.-K.; Yun, B.-S. Hispidin Derivatives from the Mushroom Inonotus x Eranticus and Their Antioxidant Activity. J. Nat. Prod. 2006, 69, 299–301. [Google Scholar] [CrossRef]
  60. Min, B.-S.; Yun, B.-S.; Lee, H.-K.; Jung, H.-J.; Jung, H.-A.; Choi, J.-S. Two Novel Furan Derivatives from Phellinus linteus with Anti-Complement Activity. Bioorganic Med. Chem. Lett. 2006, 16, 3255–3257. [Google Scholar] [CrossRef]
  61. Goodrich-Tanrikulu, M.; Howe, K.; Stafford, A.; Nelson, M.A. Changes in Fatty Acid Composition of Neurospora crassa Accompany Sexual Development and Ascospore Germination. Microbiology 1998, 144, 1713–1720. [Google Scholar] [CrossRef]
  62. Liu, P.; Ivanova-Petropulos, V.; Duan, C.; Yan, G. Effect of Unsaturated Fatty Acids on Intra-Metabolites and Aroma Compounds of Saccharomyces cerevisiae in Wine Fermentation. Foods 2021, 10, 277. [Google Scholar] [CrossRef] [PubMed]
  63. Dai, Y.-C. Hymenochaetaceae (Basidiomycota) in China. Fungal Divers. 2010, 45, 131–343. [Google Scholar] [CrossRef]
  64. Gramss, G.R.L. Gilbertson and L. Ryvarden, North American Polypores. Volume 1: Abortiporus—Lindtneria. 433 S., 209 Abb. Oslo 1986. Fungiflora A/S. J. Basic Microbiol. 1987, 27, 282. [Google Scholar] [CrossRef]
  65. Kornerup, A.; Wanscher, J.H. Methuen Handbook of Colour, 3rd ed.; Eyre Methuen: London, UK, 1978. [Google Scholar]
  66. Zheng, H.-F.; Huang, F.-C.; Liu, B.; Shao, Y.-Y.; Qin, P.-S. Fulvifomes nonggangensis and F. tubogeneratus (Hymenochaetales, Basidiomycota): Two New Species from Southern China Based on Morphological and Molecular Evidences. Mycobiology 2021, 49, 213–222. [Google Scholar] [CrossRef] [PubMed]
  67. García-Jacobo, I.; Raymundo, T.; Martínez-González, C.R.; Martínez-Pineda, M.; Valenzuela, R. Phylogenetic and Morphological Analyses Reveal Twelve New Species of the Genus Patellaria (Dothideomycetes, Ascomycota) from Mexico. J. Fungi 2025, 11, 44. [Google Scholar] [CrossRef] [PubMed]
  68. Martínez-González, C.R.; Ramírez-Mendoza, R.; Jiménez-Ramírez, J.; Gallegos-Vázquez, C.; Luna-Vega, I. Improved Method for Genomic DNA Extraction for Opuntia Mill. (Cactaceae). Plant Methods 2017, 13, 82. [Google Scholar] [CrossRef] [PubMed]
  69. White, T.J.; Bruns, T.; Lee, S.; Taylor, J. Amplification and Direct Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics. In PCR Protocols; Elsevier: Amsterdam, The Netherlands, 1990; pp. 315–322. ISBN 978-0-12-372180-8. [Google Scholar]
  70. Hall, T.A. BioEdit: A User-Friendly Biological Sequence Alignment Editor and Analysis Program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41, 95–98. [Google Scholar]
  71. Zhang, Z.; Schwartz, S.; Wagner, L.; Miller, W. A Greedy Algorithm for Aligning DNA Sequences. J. Comput. Biol. 2000, 7, 203–214. [Google Scholar] [CrossRef] [PubMed]
  72. Katoh, K.; Standley, D.M. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability. Mol. Biol. Evol. 2013, 30, 772–780. [Google Scholar] [CrossRef]
  73. Müller, K.; Quandt, D.; Müller, J. PhyDE®-Phylogenetic Data Editor. Program Distributed by the Author 2010. Available online: http://www.phyde.de (accessed on 3 March 2025).
  74. Peng, J.; Swofford, D.L.; Kubatko, L. Estimation of Speciation Times under the Multispecies Coalescent. Bioinformatics 2022, 38, 5182–5190. [Google Scholar] [CrossRef]
  75. Nguyen, L.-T.; Schmidt, H.A.; Von Haeseler, A.; Minh, B.Q. IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies. Mol. Biol. Evol. 2015, 32, 268–274. [Google Scholar] [CrossRef] [PubMed]
  76. Ronquist, F.; Teslenko, M.; Van Der Mark, P.; Ayres, D.L.; Darling, A.; Höhna, S.; Larget, B.; Liu, L.; Suchard, M.A.; Huelsenbeck, J.P. MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space. Syst. Biol. Syst. Biol. 2012, 61, 539–542. [Google Scholar] [CrossRef] [PubMed]
  77. Lanfear, R.; Frandsen, P.B.; Wright, A.M.; Senfeld, T.; Calcott, B. PartitionFinder 2: New Methods for Selecting Partitioned Models of Evolution for Molecular and Morphological Phylogenetic Analyses. Mol. Biol. Evol. 2016, 34, 772–773. [Google Scholar] [CrossRef]
  78. Rambaut, A.; Drummond, A.J.; Xie, D.; Baele, G.; Suchard, M.A. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst. Biol. 2018, 67, 901–904. [Google Scholar] [CrossRef]
  79. Rambaut, A. FigTree—A Graphical Viewer of Phylogenetic Trees, v.1.4.4.; Institute of Evolutionary Biology, Univ of Edinburgh 2018. Available online: http://tree.bio.ed.ac.uk/software/figtree (accessed on 10 March 2025).
  80. Abdullah, S.; Jang, S.-E.; Kwak, M.-K.; Chong, K. Ganoderma boninense Mycelia for Phytochemicals and Secondary Metabolites with Antibacterial Activity. J. Microbiol. 2020, 58, 1054–1064. [Google Scholar] [CrossRef]
  81. Chakarwarti, J.; Anand, V.; Nayaka, S.; Srivastava, S. In Vitro Antibacterial Activity and Secondary Metabolite Profiling of Endolichenic Fungi Isolated from Genus Parmotrema. Curr. Microbiol. 2024, 81, 195. [Google Scholar] [CrossRef] [PubMed]
  82. Weinstein, M.P.; Patel, J.B. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: M07-A11, 11th ed.; Documents/Clinical and Laboratory Standards Institute; Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2018; ISBN 978-1-56238-836-2. [Google Scholar]
  83. Ibarra, J.A.; Knodler, L.A.; Sturdevant, D.E.; Virtaneva, K.; Carmody, A.B.; Fischer, E.R.; Porcella, S.F.; Steele-Mortimer, O. Induction of Salmonella Pathogenicity Island 1 under Different Growth Conditions Can Affect Salmonella–Host Cell Interactions in Vitro. Microbiology 2010, 156, 1120–1133. [Google Scholar] [CrossRef]
  84. Choo, J.H.; Rukayadi, Y.; Hwang, J.-K. Inhibition of Bacterial Quorum Sensing by Vanilla Extract. Lett. Appl. Microbiol. 2006, 42, 637–641. [Google Scholar] [CrossRef]
  85. El-Elimat, T.; Figueroa, M.; Ehrmann, B.M.; Cech, N.B.; Pearce, C.J.; Oberlies, N.H. High-Resolution MS, MS/MS, and UV Database of Fungal Secondary Metabolites as a Dereplication Protocol for Bioactive Natural Products. J. Nat. Prod. 2013, 76, 1709–1716. [Google Scholar] [CrossRef]
  86. Mohimani, H.; Gurevich, A.; Shlemov, A.; Mikheenko, A.; Korobeynikov, A.; Cao, L.; Shcherbin, E.; Nothias, L.-F.; Dorrestein, P.C.; Pevzner, P.A. Dereplication of Microbial Metabolites through Database Search of Mass Spectra. Nat. Commun. 2018, 9, 4035. [Google Scholar] [CrossRef]
  87. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and Community Curation of Mass Spectrometry Data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [PubMed]
  88. Schmid, R.; Heuckeroth, S.; Korf, A.; Smirnov, A.; Myers, O.; Dyrlund, T.S.; Bushuiev, R.; Murray, K.J.; Hoffmann, N.; Lu, M.; et al. Integrative Analysis of Multimodal Mass Spectrometry Data in MZmine 3. Nat. Biotechnol. 2023, 41, 447–449. [Google Scholar] [CrossRef] [PubMed]
  89. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; et al. MassBank: A Public Repository for Sharing Mass Spectral Data for Life Sciences. J. Mass. Spectrom. 2010, 45, 703–714. [Google Scholar] [CrossRef] [PubMed]
  90. Van Der Hooft, J.J.J.; Wandy, J.; Barrett, M.P.; Burgess, K.E.V.; Rogers, S. Topic Modeling for Untargeted Substructure Exploration in Metabolomics. Proc. Natl. Acad. Sci. USA 2016, 113, 13738–13743. [Google Scholar] [CrossRef]
  91. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef]
  92. Schymanski, E.L.; Jeon, J.; Gulde, R.; Fenner, K.; Ruff, M.; Singer, H.P.; Hollender, J. Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence. Environ. Sci. Technol. 2014, 48, 2097–2098. [Google Scholar] [CrossRef]
  93. Shun, Z.; Silverberg, A.; Chang, C.K.; Ouyang, P. Dunnett’s Many-to-One Test and Least Square Means. J. Biopharm. Stat. 2003, 13, 17–28. [Google Scholar] [CrossRef]
Figure 2. Effect of F. mexicanus sp. nov. methanolic extract on bacterial motility. Panels (A,B) show the growth curves of S. typhimurium ATCC 7251 and P. aeruginosa ATCC 9027, respectively. Panels (C,D) show the motility assay in S. typhimurium ATCC 7251, and (E,F) of P. aeruginosa ATCC 9027. We noted significant difference from control generated by Dunnet’s test, *** p < 0.0001.
Figure 2. Effect of F. mexicanus sp. nov. methanolic extract on bacterial motility. Panels (A,B) show the growth curves of S. typhimurium ATCC 7251 and P. aeruginosa ATCC 9027, respectively. Panels (C,D) show the motility assay in S. typhimurium ATCC 7251, and (E,F) of P. aeruginosa ATCC 9027. We noted significant difference from control generated by Dunnet’s test, *** p < 0.0001.
Molecules 30 02278 g002
Figure 3. (A) Effect of F. mexicanus sp. nov. methanolic extract on growth and (B) specific violacein production of C. violaceum CV026. Significant difference with respect to control was noted (Dunnet’s test), *** p < 0.0001; ** p < 0.01.
Figure 3. (A) Effect of F. mexicanus sp. nov. methanolic extract on growth and (B) specific violacein production of C. violaceum CV026. Significant difference with respect to control was noted (Dunnet’s test), *** p < 0.0001; ** p < 0.01.
Molecules 30 02278 g003
Figure 4. Molecular networking analysis of F. mexicanus sp. nov. methanolic extracts with automatic (by GNPS) and manual annotations. Molecular formulas correspond to the observed adduct.
Figure 4. Molecular networking analysis of F. mexicanus sp. nov. methanolic extracts with automatic (by GNPS) and manual annotations. Molecular formulas correspond to the observed adduct.
Molecules 30 02278 g004
Table 1. Annotation of metabolites in F. mexicanus sp. nov. extract by GNPS.
Table 1. Annotation of metabolites in F. mexicanus sp. nov. extract by GNPS.
CompoundObserved Ion (m/z) aAdduct aMolecular Formula (Adduct)Exact MassMass Accuracy (ppm)
13-Keto-9Z,11E-octadecadienoic acid295.2281[M + H]+C18H31O3295.2268+4.5
9-Oxo-10E,12Z-octadecadienoic acid295.228[M + H]+C18H31O3295.2268+4.2
Linoleic acid279.2331[M + H]+C18H31O2279.2329+0.5
Phytosphingosine318.3016[M + H]+C18H40NO3318.3003+4.2
Ergosterol peroxide429.3378[M + H]+C28H45O3429.3363+3.4
a Values taken from the GNPS platform analysis. + symbol is not a table footer. It is the positive charge of the ion adduct.
Table 2. Manual annotation of metabolites of F. mexicanus sp. nov.
Table 2. Manual annotation of metabolites of F. mexicanus sp. nov.
CompoundObserved Ion (m/z)AdductMolecular Formula (Adduct)Exact MassMass Accuracy (ppm) aFungal Source
Interfungin A465.1201[M + H]+C25H21O9465.1180+4.5Hymenochaete xerantica
Inoscavin A465.1201[M + H]+C25H19O9463.1023+3.1Hymenochaete xerantica, Sanghuangporus baumii,
Fulvifomes fastuosus.
Phelligridin I (syn Inonoblin A)625.1013[M + H]+C33H21O13625.0977+5.8Inonotus obliquus,
Phellinus igniarius
10-O-Methylinoscavin C435.1095[M + H]+C24H19O8435.1074+4.7Hymenochaete xerantica
Phelliribsin A393.0983[M + H]+C22H17O7393.0969+3.6Phylloporia ribis
Hymenoquinone (E)-form261.0404[M + H]+C13H9O6261.0394+4.0Hymenochaete mougeotii
Phellibaumin D425.0883[M + H]+C22H17O9425.0867+3.7Sanghuangporus baumii
Inonoalliacane I351.1814[M + H]+C19H27O6351.1802+3.4Inonotus sp.
Phelligridin D379.0475[M + H]+C20H13O8381.0605+2.9Inonotus obliquus,
Phellinus igniarius,
Phellinus linteus
Inoscavin C421.0930[M + H]+C23H17O8421.0918+2.9Phellinus ellipsoideus,
Hymenochaete xerantica,
Phellinus igniarius.
Inoscavin E379.0823[M + H]+C21H15O7379.0812+2.8Phellinus linteus,
Hymenochaete xerantica
a Values obtained from GNPS and LC-HRMS-MS/MS analysis. + symbol is not a table footer. It is the positive charge of the ion adduct.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bolaños-Nuñez, A.; Martínez-Pineda, M.; Valenzuela, R.; Figueroa, M.; D. Patiño, A.; Curiel-Quesada, E.; Martínez-Gonzáles, C.R.; Villanueva-Silva, R.; Raymundo, T.; Pérez-Valdespino, A. Quorum Sensing and Mobility Inhibition of Pathogenic Bacteria by Fulvifomes mexicanus sp. nov. Molecules 2025, 30, 2278. https://doi.org/10.3390/molecules30112278

AMA Style

Bolaños-Nuñez A, Martínez-Pineda M, Valenzuela R, Figueroa M, D. Patiño A, Curiel-Quesada E, Martínez-Gonzáles CR, Villanueva-Silva R, Raymundo T, Pérez-Valdespino A. Quorum Sensing and Mobility Inhibition of Pathogenic Bacteria by Fulvifomes mexicanus sp. nov. Molecules. 2025; 30(11):2278. https://doi.org/10.3390/molecules30112278

Chicago/Turabian Style

Bolaños-Nuñez, Angelica, Michelle Martínez-Pineda, Ricardo Valenzuela, Mario Figueroa, Albert D. Patiño, Everardo Curiel-Quesada, César Ramiro Martínez-Gonzáles, Rodrigo Villanueva-Silva, Tania Raymundo, and Abigail Pérez-Valdespino. 2025. "Quorum Sensing and Mobility Inhibition of Pathogenic Bacteria by Fulvifomes mexicanus sp. nov." Molecules 30, no. 11: 2278. https://doi.org/10.3390/molecules30112278

APA Style

Bolaños-Nuñez, A., Martínez-Pineda, M., Valenzuela, R., Figueroa, M., D. Patiño, A., Curiel-Quesada, E., Martínez-Gonzáles, C. R., Villanueva-Silva, R., Raymundo, T., & Pérez-Valdespino, A. (2025). Quorum Sensing and Mobility Inhibition of Pathogenic Bacteria by Fulvifomes mexicanus sp. nov. Molecules, 30(11), 2278. https://doi.org/10.3390/molecules30112278

Article Metrics

Back to TopTop